|
Real-time Estimate
Cboe BZX
10:03:05 15/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 215.82 USD | -0.71% |
|
+1.47% | +22.52% |
| 14/09 | Biogen Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 09:15 AM | |
| 12/09 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
| Market Cap | 3.21TCr 2.78TCr 2.63TCr 2.38TCr 4.47TCr 3,08100Cr 4.5TCr 31TCr 12TCr 1,56200Cr 12TCr 12TCr 4,98200Cr | P/E 2026 * |
37.5x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.71TCr 3.21TCr 3.03TCr 2.75TCr 5.16TCr 3,55400Cr 5.2TCr 36TCr 14TCr 1,80200Cr 14TCr 14TCr 5,74800Cr | EV / Sales 2026 * |
3.55x | EV / Sales 2027 * | 3.24x |
| Free-Float |
85.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Xetra
| IDP | Delayed | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | -0.71% | ||
| 1 week | +1.47% | ||
| Current month | -0.48% | ||
| 1 month | +3.09% | ||
| 3 months | +8.55% | ||
| 6 months | +17.66% | ||
| Current year | +22.52% |
| 1 week | 208.93 |  | 222.24 |
| 1 month | 207.62 | | 225.8 |
| Current year | 160.36 | | 225.8 |
| 1 year | 135.39 | | 225.8 |
| 3 years | 110.04 | | 269.43 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 04/08/26 | Sell | Director | -593 | 0.0004% | ||
| 09/06/26 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.71% | +1.47% | +50.45% | -15.37% | 3.21TCr | |
| -1.28% | -3.90% | +36.00% | -5.42% | 7.93TCr | |
| -1.62% | +1.62% | +497.19% | +24.45% | 5.86TCr | |
| +1.57% | +0.62% | -16.15% | -34.72% | 5.86TCr | |
| -0.56% | -3.68% | -11.53% | +25.63% | 4.87TCr | |
| -0.29% | +1.45% | +2.14% | +149.29% | 4.63TCr | |
| -0.59% | -2.68% | +45.61% | +93.54% | 2.48TCr | |
| -1.91% | -6.22% | -2.91% | +151.66% | 2.15TCr | |
| -1.92% | -3.81% | +61.03% | +96.07% | 1.6TCr | |
| -5.40% | -8.41% | +33.04% | +135.07% | 1.41TCr | |
| Average | -1.27% | -2.02% | +69.49% | +62.02% | 4TCr | |
| Weighted average by Cap. | -0.84% | -1.88% | +86.73% | +39.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.04TCr 904.67Cr 855.45Cr 774.47Cr 1.45TCr 1,00200Cr 1.46TCr 10TCr 3.93TCr 51TCr 3.92TCr 3.84TCr 1,62000Cr | 1.07TCr 923.04Cr 872.83Cr 790.2Cr 1.48TCr 1,02200Cr 1.49TCr 10TCr 4.01TCr 52TCr 4TCr 3.91TCr 1,65300Cr |
| Net income | 96Cr 83Cr 79Cr 71Cr 134.14Cr 9.25TCr 135.15Cr 942.1Cr 362.45Cr 4.69TCr 362.05Cr 354.02Cr 15TCr | 185.54Cr 160.72Cr 151.97Cr 137.59Cr 258.22Cr 18TCr 260.17Cr 1.81TCr 697.73Cr 9.02TCr 696.95Cr 681.5Cr 29TCr |
| Net Debt | 493.67Cr 427.62Cr 404.36Cr 366.08Cr 687.06Cr 47TCr 692.23Cr 4.83TCr 1.86TCr 24TCr 1.85TCr 1.81TCr 77TCr | 242Cr 209.62Cr 198.22Cr 179.45Cr 336.8Cr 23TCr 339.33Cr 2.37TCr 910.04Cr 12TCr 909.03Cr 888.87Cr 38TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | $215.62 | -0.80% | 2,23,048 |
| 14/26/14 | $217.36 | +0.10% | 6,29,931 |
| 11/26/11 | $217.15 | +0.80% | 10,75,556 |
| 10/26/10 | $215.43 | +2.23% | 9,36,643 |
| 09/26/09 | $210.73 | -0.83% | 6,94,669 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
